United KingdomUS researchers have used artificial intelligence to design 16 novel viruses capable of replicating in the laboratory. These viruses, known as bacteriophages, were engineered to target specific bacteria such as E. coli and do not pose a risk to humans. This marks the first time generative AI has been used to create a complete functional genome. The development is considered a major scientific advancement with potential applications in treating antibiotic-resistant infections. However, experts warn of urgent safety and security concerns related to the use of AI in creating new biological entities.
Bias read (Center): The article presents a balanced overview of the scientific achievement and the associated concerns without taking a stance on either side. It includes quotes from researchers highlighting both the potential benefits and the risks involved.
